PPI Dosing Per CYP2C19 Genotype
Key facts
- Who runs it
- University of Florida
- Where
- Jacksonville, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 4
- People taking part
- 200 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 1 Apr 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- CYP2C19 based dosing Proton Pump Inhibitors
- Conventional proton pump inhibitor dose
- Record updated
- 12 November 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- age ≥ 18 years
- diagnosis of Gastroesophageal Reflux Disease (GERD) scheduled for an esophagogastroduodenoscopy (EGD)
- patients diagnosed with Erosive Esophagitis on endoscopy (EGD)
Who cannot take part
- diagnosed with non-erosive reflux disease (NERD)
- age <18 years
- pregnancy
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
This trial is currently available in United States.
- UF HealthJacksonville, United StatesContact: Ruchir Puri, MDTaking people
About the trial
What the trial wants to find out
This study is being done to determine if the dosing of proton pump inhibitor (PPI) medication based on CYP2C19 genotype-derived phenotype leads to improved healing of erosive esophagitis compared to conventional PPI medication dosing.
The 2 groups in the trial
- InterventionTreatment being tested
proton pump inhibitor dose based on CYP2C19 phenotypes
Treatment: CYP2C19 based dosing Proton Pump Inhibitors
- ControlExisting treatment, for comparison
conventional proton pump inhibitor dose of Pantoprazole 40 mg once or twice daily
Treatment: Conventional proton pump inhibitor dose
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pilot Study to Assess Healing of Erosive Esophagitis in Patients Randomized to Conventional PPI Doses Versus Dosing Based on CYP2C19 Genotype
- Criteria questions
- Built from NCT07843264, who can take part
- Record updated
- 12 November 2026